Prospective study of Streptococcus milleri hepatic abscess

被引:13
作者
Corredoira, J
Casariego, E
Moreno, C
Villanueva, L
Alvarez, MJL
Varela, J
Rodríguez, A
Alonso, P
Coira, A
机构
[1] Hosp Xeral Calde, Dept Internal Med, E-27004 Lugo, Spain
[2] Hosp Xeral Calde, Dept Microbiol, E-27004 Lugo, Spain
关键词
D O I
10.1007/s100960050129
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Thirty-seven cases of microbiologically demonstrated pyogenic hepatic abscess were observed in a prospective study over a seven-year period. Biliary disease was the most common source of liver abscess (42%). Streptococcus milleri was the most common cause of hepatic abscess, accounting for 51% of the cases. Hepatic abscess is due to Streptococcus milleri clinically distinct from other forms of pyogenic liver abscess due to its torpid nature and the longer duration of its symptoms [42 vs. 11 days]. Occult hepatic abscess should be suspected if the blood culture is positive for Streptococcus milleri, since 28% of bacteremia cases due to Streptococcus milleri stem from hepatic abscesses. It is important to distinguish Streptococcus milleri from other members of the viridans streptococci group, which are frequently isolated as contaminants, but only exceptionally cause hepatic abscess. Unlike other pyogenic hepatic abscesses, those caused by Streptococcus milleri are frequently monomicrobial (79%). In the present study, empirical therapy of pyogenic hepatic abscess always included a drug that is effective against Streptococcus milleri.
引用
收藏
页码:556 / 560
页数:5
相关论文
共 41 条
[1]   IN-VITRO ACTIVITIES OF 22-BETA-LACTAM ANTIBIOTICS AGAINST PENICILLIN-RESISTANT AND PENICILLIN-SUSCEPTIBLE VIRIDANS GROUP STREPTOCOCCI ISOLATED FROM BLOOD [J].
ALCAIDE, F ;
LINARES, J ;
PALLARES, R ;
CARRATALA, J ;
BENITEZ, MA ;
GUDIOL, F ;
MARTIN, R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (10) :2243-2247
[2]  
ALLISON HF, 1984, S AFR MED J, V65, P432
[3]  
Altemeier W A, 1971, Del Med J, V43, P327
[4]  
BATEMAN NT, 1975, LANCET, V1, P657
[5]  
BAUER AW, 1966, AM J CLIN PATHOL, V45, P493
[6]  
BERGER LA, 1982, LANCET, V1, P132
[7]   HEPATIC-ABSCESS - CHANGES IN ETIOLOGY, DIAGNOSIS, AND MANAGEMENT [J].
BRANUM, GD ;
TYSON, GS ;
BRANUM, MA ;
MEYERS, WC .
ANNALS OF SURGERY, 1990, 212 (06) :655-662
[8]   STREPTOCOCCUS-MG-INTERMEDIUS (STREPTOCOCCUS-MILLERI) HEPATIC-ABSCESSES IN 2 PATIENTS WITH REGIONAL ENTERITIS [J].
BRASITUS, TA ;
CLERI, DJ ;
SZABO, K .
SOUTHERN MEDICAL JOURNAL, 1983, 76 (10) :1297-1298
[9]   Prospective study of Streptococcus milleri bacteremia [J].
Casariego, E ;
Rodriguez, A ;
Corredoira, JC ;
Alonso, P ;
Coira, A ;
Bal, M ;
Lopez, MJ ;
Varela, J .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1996, 15 (03) :194-200
[10]  
Chu KM, 1996, ARCH SURG-CHICAGO, V131, P148